Synthesis and Characterization of Novel pH-Sensitive Hydrogels Containing Ibuprofen Pen dents for Colon-Specific Drug Delivery

  • Mahkam, Mehrdad (Chemistry Department, Azarbaijan University of Tarbiat Moallem) ;
  • Poorgholy, Nahid (Chemistry Department, Azarbaijan University of Tarbiat Moallem) ;
  • Vakhshouri, Laleh (Chemistry Department, Azarbaijan University of Tarbiat Moallem)
  • 발행 : 2009.09.25

초록

The aim of this study was to develop novel intestinal specific drug delivery systems with pH sensitive swelling and drug release properties. The carboxyl group of ibuprofen was converted to a vinyl ester group by reacting ibuprofen and vinyl acetate as an acylating agent in the presence of catalyst. The glucose-6-acrylate-1, 2, 3, 4-tetraacetate (GATA) monomer was prepared under mild conditions. Cubane-1, 4-dicarboxylic acid (CDA) linked to two 2-hydroxyethyl methacrylate (HEMA) group was used as the crosslinking agent (CA). Methacrylic-type polymeric prodrugs were synthesized by the free radical copolymerization of methacrylic acid, vinyl ester derivative of ibuprofen (VIP) and GATA in the presence of cubane cross linking agent. The structure of VIP was characterized and confirmed by FTIR, $^1H$ NMR and $^{13}C$ NMR spectroscopy. The composition of the cross-linked three-dimensional polymers was determined by FTIR spectroscopy. The hydrolysis of drug polymer conjugates was carried out in cel-lophane membrane dialysis bags, and the in vitro release profiles were established separately in enzyme-free simulated gastric and intestinal fluids (SGF, pH 1 and SIF, pH 7.4). The detection of a hydrolysis solution by UV spectroscopy at selected intervals showed that the drug can be released by hydrolysis of the ester bond between the drug and polymer backbone at a low rate. Drug release studies showed that increasing the MAA content in the copolymer enhances the rate of hydrolysis in SIP. These results suggest that these polymeric prodrugs can be useful for the release of ibuprofen in controlled release systems.

키워드

참고문헌

  1. M. K. Chourasia and S. K. Jain, J. Pharm. Pharma. Sci., 6, 33 (2003)
  2. S. K. Bajpai and S. Saxena, J. Appl. Polym. Sci., 92, 3630 (2004) https://doi.org/10.1002/app.20283
  3. H. Brø ndsted and J. Kopecek, Biomaterials, 12, 584 (1991) https://doi.org/10.1016/0142-9612(91)90056-G
  4. B. Kim and N. A. Peppas, J. Biomater. Sci. Polym. Edn., 13, 1271 (2002) https://doi.org/10.1163/156856202320893000
  5. S. P. Baldwin and W. M. Saltzman, Adv. Drug Deliv. Rev., 33, 71 (1998) https://doi.org/10.1016/S0169-409X(98)00021-0
  6. W. R. Gombotz and D. K. Pettite, Bioconjug. Chem., 6, 332 (1995) https://doi.org/10.1021/bc00034a002
  7. M. Saffran, G. C. Kumar, C. Savariar, J. C. Burnham, F. Williams, and D. C. Necker, Science, 233, 1081 (1986) https://doi.org/10.1126/science.3526553
  8. H. C. Chiu, G. H. Hsiue, Y. P. Lee, and L. W. Huang, J. Biomater. Sci. Polym. Ed., 10, 591 (1999) https://doi.org/10.1163/156856299X00504
  9. M. Mahkam, J. Bioact. Comp. Polym., 19, 209 (2004) https://doi.org/10.1177/0883911504044454
  10. A. Rubinstein, J. Drug Devel. Res., 50, 435 (2000) https://doi.org/10.1002/1098-2299(200007/08)50:3/4<435::AID-DDR26>3.0.CO;2-5
  11. K. Hoste, K. Winne, and E. Schacht, Int. J. Pharm., 277, 119 (2004) https://doi.org/10.1016/j.ijpharm.2003.07.016
  12. J. Khandare and T. Minko, Prog. Polym. Sci., 31, 359 (2006) https://doi.org/10.1016/j.progpolymsci.2005.09.004
  13. M. Mahkam and L. Doostie, Drug Deliv., 12, 343 (2005) https://doi.org/10.1080/10717540590952627
  14. A. J. M. D’'Souza and E. M. Topp, J. Pharm. Sci., 93, 1962 (2004) https://doi.org/10.1002/jps.20096
  15. W. J. Zhou, M. E. Wilson, M. J. Kurth, Y. L. Hsieh, J. M. Krochta, and C. F. Shoemaker, Macromolecules, 30, 7063 (1997) https://doi.org/10.1021/ma970873m
  16. X. Chen, J. S. Dordick, and D. G. Rethwisch, Macromolecules, 28, 6014 (1995) https://doi.org/10.1021/ma00122a005
  17. B. D. Martin, S. A. Ampofo, R. J. Linhardt, and J. S. Dordick, Macromolecules, 25, 7081 (1992) https://doi.org/10.1021/ma00052a001
  18. J. S. Dordick, R. J. Linhardt, and D. G. Rethwisch, Chemtech., 24, 33 (1994)
  19. W. P. Lin, M. Hu, Y. L. Hsieh, M. Kurth, and J. M. Krochta, J. Polym. Sci. Polym. Chem. Ed., 36, 979 (1998) https://doi.org/10.1002/(SICI)1099-0518(19980430)36:6<979::AID-POLA13>3.0.CO;2-I
  20. L. Erdmann, C. Campo, C. Bedell, and K. Uhrich, ACS Symp. Ser., 709, 83 (1998) https://doi.org/10.1021/bk-1998-0709.ch005
  21. T. Ouchi and Y. Ohya, Prog. Polym. Sci., 20, 211 (1995) https://doi.org/10.1016/0079-6700(94)00031-V
  22. M. Mahkam, M. Assadi, and R. Mohammadzadeh, Macromol. Res., 14, 34 (2006) https://doi.org/10.1007/BF03219065
  23. G. Khang, J. M. Rhee, J. K. Jeong, J. S. Lee, M. S. Kim, S. H. Cho, and H. B. Lee, Macromol. Res., 11, 2073 (2003)
  24. S. Davaran and A. A. Entezami, J. Control. Release, 47, 41 (1997) https://doi.org/10.1016/S0168-3659(96)01614-8
  25. M. Mahkam, N. Sharifi, and A. A. Entezami, J. Bioact. Comp. Polym., 15, 396 (2000) https://doi.org/10.1106/M3WA-3MEW-XYYN-V3J4
  26. M. Mahkam, Drug Deliv., 14, 147 (2007) https://doi.org/10.1080/10717540601067745
  27. United States Pharmacopeia 26/National Formulary 21, US Pharmacopeial Convention, Rockwille 1999, pp 2130-2143
  28. K. V. Ranga Rao and P. Buri, Int. J. Pharma., 52, 265 (1989) https://doi.org/10.1016/0378-5173(89)90229-9
  29. H. Yang, E. Henke, and U. T. Bornscheuer, J. Org. Chem., 64, 1709 (1999) https://doi.org/10.1021/jo981780l
  30. X. Q. Cai, N. Wang, and X. F. Lin, J. Mol. Catal. B: Enzym., 40, 51 (2006) https://doi.org/10.1016/j.molcatb.2006.02.017
  31. T. M. Kumar, W. Paul, C. P. Sharma, and M. A. Kuriachan, Trends Biomater. Artif. Organs, 18, 198 (2005)
  32. M. Mahkam, M. G. Assadi, and N. Golipour, Des. Monomers Polym., 9, 607 (2006) https://doi.org/10.1163/156855506778944019
  33. J. Kope$\breve{c}$ ek, P. Kope kov$\acute{a}$, H. Brø ndsted, R. Rathi, B. $\breve{R}$iho$\acute{a}$, P. Y. Yeh, and K. Ikesue, J. Control. Release, 19, 121 (1992) https://doi.org/10.1016/0168-3659(92)90070-8